Retrospective Study
Copyright ©The Author(s) 2022.
World J Gastrointest Oncol. Dec 15, 2022; 14(12): 2367-2379
Published online Dec 15, 2022. doi: 10.4251/wjgo.v14.i12.2367
Table 4 Follow-up status of patients 1 and 3 mo after operation, n (%)
Follow-up status
D-TACE (15 cases)
C-TACE (58 cases)
χ2 value
P value
Efficacy evaluation one month postoperative3.3070.347
CR2 (13.3)20 (34.5)
PR8 (53.3)21 (36.2)
SD3 (20.0)7 (12.1)
PD2 (13.3)10 (17.2)
Evaluation of curative effect in 3 mo postoperative4.0910.252
CR2 (13.3)18 (31.0)
PR7 (46.7)21 (36.2)
SD0 (0.0)5 (8.6)
PD6 (40.0)14 (24.1)
Number of interventional treatments10.4440.005
115 (100.0)32 (55.2)
20 (0.0)24 (41.4)
30 (0.0)2 (3.4)